Use of porcine trypsin used in the manufacture of human biological medicinal products

Current effective version

PDF iconAdopted guideline

Reference numberEMA/CHMP/BWP/814397/2011
Effective from01/09/2014
KeywordsPorcine trypsin, adventitious agents, virus
DescriptionThis document covers the viral safety aspects of human biological medicinal products using porcine trypsin.

Document history

First version

Current version

PDF iconAdopted guideline

PDF iconOverview of comments

PDF iconDraft guideline

PDF iconConcept paper

In operation: 01/09/2014–present

Published: 04/03/2014

Published: 01/03/2013

Published: 20/11/2008

Related content

How useful was this page?

Add your rating